Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Iovance Biotherapeutics Inc. Common Stock (IOVA) vs Vipshop Holdings Ltd - ADR (VIPS) Price & Performance

Iovance Biotherapeutics Inc. Common StockTrade
Vipshop Holdings Ltd - ADRTrade

Price performance (Past 24H)

Key statistics

Iovance Biotherapeutics Inc. Common Stock vs Vipshop Holdings Ltd - ADR — how do they compare? Iovance Biotherapeutics Inc. Common Stock trades at $14.63 (market cap $6.04B), while Vipshop Holdings Ltd - ADR trades at $12.96 (market cap $6.05B). The key difference: Iovance Biotherapeutics Inc. Common Stock and Vipshop Holdings Ltd - ADR are close in size by market cap, and Vipshop Holdings Ltd - ADR pays a 4.87% dividend while Iovance Biotherapeutics Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Iovance Biotherapeutics Inc. Common Stock for 0 Days and Vipshop Holdings Ltd - ADR for 49 Days on average.

IOVAVIPS
Market Cap
$6.04B$6.05B
Volume
14,805,9933,719,230
Sector
HealthConsumer Cyclical
52-Week High
$14.82$20.29
52-Week Low
$1.81$12.09
Typical Hold Time
0 Days49 Days
Enterprise Value
$5.97B$2.87B
Dividend Yield
—4.87%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Iovance Biotherapeutics Inc. Common Stock

No Aura AI signal available yet.

Vipshop Holdings Ltd - ADR

Vipshop Holdings (VIPS) trades at $12.98, up 1.61% with mixed technical signals showing neutral overall momentum. The stock trades at attractive valuation multiples including P/E of 4.1x and P/S of 0.4x, supported by strong profitability with 24.4% ROE. Recent earnings showed Q2 2026 miss with $0.12 EPS versus $0.59 expected, reflecting challenging retail conditions as revenue declined to $105.9B in 2025.

The investment case balances deep value metrics against growth headwinds. Analyst consensus targets $16.17 (25% upside) with 54% buy ratings, though recent earnings misses and consumer spending concerns create near-term uncertainty. The company maintains strong cash generation with $9.1B operating cash flow in 2024, supporting shareholder returns.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

IOVA
100% Buy0% Sell
Avg holding period · 0 Days
VIPS
0% Buy100% Sell
Avg holding period · 49 Days

About Iovance Biotherapeutics Inc. Common Stock

Iovance Biotherapeutics develops cell therapies for cancer. Its approach uses tumor-infiltrating lymphocytes, or TIL, to target solid tumors.

Read more on IOVA →

About Vipshop Holdings Ltd - ADR

Vipshop Holdings Ltd is an online discount retailer for brands in China. The company offers branded products to consumers in China through flash sales on its vipshop.com, vip.com and lefeng.com websites. Flash sales represent an online retail format combining the advantages of e-commerce and discount sales through selling a finite quantity of discounted products or services online for a limited period of time. It deals in a wide range of products and services for consumers specializing in branded cosmetics, apparel, healthcare products, food and other consumer products. Its operating segment includes Vip.com and Shan Shan Outlets. The company generates maximum revenue from Vip.com segment.

Read more on VIPS →